CLINICAL_TRIALS trial_result · 2013-04-26

Clinical Trial Update: Trial of a Sustained Release Methylphenidate in the Treatment of Fatigue in Cancer Patients [Phase 3]

Phase 3 trial of a sustained release methylphenidate for fatigue in cancer patients was terminated; results posted in 2013.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: M.D. Anderson Cancer Center | Conditions: Breast Cancer, Fatigue | Phase 3 | Status: TERMINATED | Results posted: 2013-04-26